Seven Eight Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-58,292
| Closed | -$911K | – | 425 |
|
|
2024
Q3 | $911K | Sell |
58,292
-3,617
| -6% | -$56.5K | 0.08% | 427 |
|
|
2024
Q2 | $1.06M | Buy |
+61,909
| New | +$1.06M | 0.11% | 339 |
|
|
2024
Q1 | – | Sell |
-109,432
| Closed | -$1.63M | – | 751 |
|
|
2023
Q4 | $1.63M | Sell |
109,432
-28,289
| -21% | -$422K | 0.19% | 154 |
|
|
2023
Q3 | $2.22M | Buy |
137,721
+71,989
| +110% | +$1.16M | 0.26% | 100 |
|
|
2023
Q2 | $2.73M | Buy |
+65,732
| New | +$2.73M | 0.45% | 60 |
|
|
2018
Q4 | – | Sell |
-48,301
| Closed | -$2.53M | – | 661 |
|
|
2018
Q3 | $2.53M | Buy |
+48,301
| New | +$2.53M | 0.15% | 204 |
|
|
2018
Q1 | – | Sell |
-33,600
| Closed | -$679K | – | 490 |
|
|
2017
Q4 | $679K | Buy |
+33,600
| New | +$679K | 0.07% | 299 |
|